HBV Citations List: April 2023

Literature Citations

1. Synthesis of 1,2,3-Triazole-linked Hexopyranosylpyrimidine nucleosides and Their Application as Hepatitis B Viral DNA, HBsAg and HBeAg Suppressants. Verma, V., A. Singh, P. Tyagi, V. Kumar, and A.K. Prasad. ChemistrySelect, 2023. 8(12): e202204982. ISI[000954026400001].
[WOS]. HBV_04_2023.

2. Synthesis and Biological Evaluation of Esculetin Derivatives as Potential anti-HBV Agents. Ye, Z., T.S.Y. Zhao, S.B. Li, X.L. Zhou, Q. Luo, J.K. Qin, C.Q. Liang, P. Wang, and G.B. Ge. Medicinal Chemistry Research, 2023. 32(5): p. 899-909. PMID[37056462]. PMCID[PMC10030075].
[PubMed]. HBV_04_2023.

Patent Citations

This month, no relevant HBV patents were identified.